Tipranavir



- TRADE NAME: Aptivus (Boehringer Ingelheim)
- INDICATIONS: Antiretroviral treatment of HIV-1
- CLASS: HIV-1 protease inhibitor, Sulfonamide
- HALF-LIFE: 4.8–6.0 hours
Abacavir, Alcohol, Alfuzosin, Alprazolam, Amiodarone, Antacids, Antifungals, Apixaban, Artemether/Lumefantrine, Atazanavir, Atomoxetine, Atorvastatin, Bepridil, Bosentan, Buprenorphine, Calcium channel blockers, Carbamazepine, Cisapride, Clarithromycin, Codeine, Conivaptan, Copanlisib, Corticosteroids, Cyclosporine, CYP2D6 substrates, CYP3A4 inducers, Dabigatran, Darifenacin, Deferasirox, Delavirdine, Didanosine, Digoxin, Dihydroergotamine, Disulfiram, Efavirenz, Elbasvir & Grazoprevir, Eluxadoline, Enfuvirtide, Eplerenone, Ergotamine, Esomeprazole, Estradiol, Estrogens, Etravirine, Fesoterodine, Flecainide, Fluconazole, Fosamprenavir, Fusidic Acid, Garlic, HMG-CoA reductase inhibitors, Lopinavir, Lovastatin, Meperidine, Methadone, Metoprolol, Metronidazole, Midazolam, Midostaurin, Nebivolol, Nefazodone, Neratinib, Omeprazole, P-glycoprotein substrates, Pantoprazole, Phenobarbital, Phenytoin, Pimozide, Propafenone, Protease inhibitors, Proton pump inhibitors, Quetiapine, Quinidine, Quinine, Raltegravir, Ranolazine, Rifabutin, Rifampin, Rilpivirine, Rivaroxaban, Rosuvastatin, Salmeterol, Saquinavir, Sildenafil, Simeprevir, Simvastatin, Sirolimus, Sofosbuvir, Sofosbuvir/Velpatasvir/Voxilaprevir, St John's Wort, Tacrolimus, Tamoxifen, Telithromycin, Temsirolimus, Tenofovir Disoproxil, Tetrabenazine, Theophylline, Thioridazine, Tramadol, Trazodone, Triazolam, Tricyclic antidepressants, Valproic Acid, Vardenafil, Viloxazine, Vitamin E, Zidovudine
PREGNANCY CATEGORY: C
Tipranavir is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.
Tipranavir is co-administered with ritonavir.
Contra-indicated in patients with moderate or severe (Child-Pugh Class B or C) hepatic impairment.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric